2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $27B | $29B | $33B | $35B | $29B |
Cost of Revenue | $25B | $27B | $31B | $32B | $26B |
Gross Profit | $1.9B | $2.4B | $2.6B | $2.9B | $2.7B |
Gross Profit % | 7.1% | 8.1% | 7.9% | 8.3% | 9.3% |
R&D Expenses | $44M | $34M | $33M | $34M | $39M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $57M | $698M | $996M | $818M | $1.4B |
Dep. & Amort. | $795M | $876M | $925M | $924M | $696M |
Def. Tax | $29M | -$13M | -$13M | $85M | -$64M |
Stock Comp. | $83M | $102M | $81M | $95M | $89M |
Chg. in WC | $120M | -$266M | -$347M | -$206M | $472M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $1.4B | $1.6B | $1.5B | $1.8B | $2.2B |
ST Investments | $17M | $18M | $16M | $25M | $0 |
Cash & ST Inv. | $1.4B | $1.6B | $1.5B | $1.8B | $2.2B |
Receivables | $2.8B | $4.1B | $5.2B | $4.7B | $4.6B |
Inventory | $3.1B | $4.4B | $6.1B | $5.2B | $4.3B |
Jabil reported strong Q2 FY25 results with $6.7B in revenue (up 3% YoY excluding divested Mobility), core operating income of $334M, core operating margin of 5%, and core diluted EPS of $1.94; adjusted free cash flow for the quarter was $261M.
Intelligent Infrastructure segment was a standout, with revenue up 18% YoY (would have been 37% excluding legacy networking), driven by robust demand in AI cloud, data center infrastructure, and capital equipment; AI-related revenue guidance for FY25 was raised to $7.5B, representing ~40% YoY growth.
FY25 guidance was raised: total revenue now expected at ~$27.9B, core operating margin at 5.4%, core EPS at $8.09, and free cash flow to exceed $1.2B; Q3 revenue expected between $6.7B–$7.3B, with core EPS of $2.08–$2.48.
Management emphasized Jabil’s strong U.S. manufacturing footprint (30 sites), resilience to potential tariff impacts, and ability to help customers navigate global supply chain shifts; most China and Mexico business is local or USMCA-compliant, minimizing tariff exposure.
Recent acquisitions in silicon photonics, liquid cooling, and pharmaceuticals are driving new growth opportunities, especially in AI/data center and healthcare; management remains prudent on EVs, renewables, and consumer markets due to ongoing macro uncertainty.